Thomas, McNerney & Partners is a venture capital and private equity firm investing in healthcare, life science, and medical technology companies at all stages that is headquartered in Stamford, Connecticut and was founded in 2003 by Karen Boezi, and Peter H. McNerney.
As of December 2019, Thomas, McNerney & Partners have made 46 investments, lead 16 investments, and had a total of 15 exits. Notable investments made by Thomas, McNerney & Partners include: Invitae, VertiFlex, Torax Medical, Auspex Pharmaceuticals, Zogenix, CAS Medical Systems, Celator Pharmaceuticals, Virdante Pharmaceuticals, Elron Electronic Industries, aSGB, and Tioga Pharmaceuticals.
Thomas, McNerney & Partners closes $375 Million Life Science & Medical Technology Fund.
A biopharmaceutical company that develops therapeutics to treat depressive disorders
A biopharmaceutical company developing treatments for diabetic complications
A pharmaceutical company specializing in developing treatments for pruritus
Documentaries, videos and podcasts